Detalhe da pesquisa
1.
Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk.
N Engl J Med
; 387(21): 1923-1934, 2022 Nov 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-36342113
2.
AAA-ATPase valosin-containing protein binds the transcription factor SREBP1 and promotes its proteolytic activation by rhomboid protease RHBDL4.
J Biol Chem
; 298(6): 101936, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35430252
3.
Loss of myeloid lipoprotein lipase exacerbates adipose tissue fibrosis with collagen VI deposition and hyperlipidemia in leptin-deficient obese mice.
J Biol Chem
; 298(9): 102322, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35926714
4.
Generation and mutational analysis of a transgenic murine model of the human MAF mutation.
Am J Med Genet A
; 191(7): 1878-1888, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37186330
5.
A case of vasoactive intestinal peptide-secreting tumor (VIPoma) arising from MEN1 inactivation which recurred 15 years after the initial resection.
Endocr J
; 70(6): 573-579, 2023 Jun 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-36889692
6.
Clinical characteristics and efficacy of pioglitazone in a Japanese patient with familial partial lipodystrophy due to peroxisome proliferator-activated receptor γ gene mutation.
Endocr J
; 70(1): 69-76, 2023 Jan 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-36171144
7.
Association of collateral flow with clinical outcomes in patients with acute myocardial infarction.
Heart Vessels
; 37(9): 1496-1505, 2022 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-35290505
8.
Effects of pemafibrate on glucose metabolism markers and liver function tests in patients with hypertriglyceridemia: a pooled analysis of six phase 2 and phase 3 randomized double-blind placebo-controlled clinical trials.
Cardiovasc Diabetol
; 20(1): 96, 2021 05 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33947390
9.
Clinical Factors Associated with Long Fluoroscopy Time in Percutaneous Coronary Interventions to the Culprit Lesion of Non-ST-Segment Elevation Myocardial Infarction.
Int Heart J
; 62(2): 282-289, 2021 Mar 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-33731534
10.
Perfusion Balloon for the Treatment of Very Late Stent Thrombosis.
Int Heart J
; 62(2): 422-426, 2021 Mar 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-33731535
11.
Esterification of 4ß-hydroxycholesterol and other oxysterols in human plasma occurs independently of LCAT.
J Lipid Res
; 61(9): 1287-1299, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32561542
12.
Critical Role of SREBP-1c Large-VLDL Pathway in Environment-Induced Hypertriglyceridemia of Apo AV Deficiency.
Arterioscler Thromb Vasc Biol
; 39(3): 373-386, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30700132
13.
The Anti-atherogenic Activity of Beauveriolide Derivative BVD327, a Sterol O-Acyltransferase 2-Selective Inhibitor, in Apolipoprotein E Knockout Mice.
Biol Pharm Bull
; 43(6): 951-958, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32475917
14.
The selective peroxisome proliferator-activated receptor alpha modulator (SPPARMα) paradigm: conceptual framework and therapeutic potential : A consensus statement from the International Atherosclerosis Society (IAS) and the Residual Risk Reduction Initiative (R3i) Foundation.
Cardiovasc Diabetol
; 18(1): 71, 2019 06 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31164165
15.
Efficacy and safety of pemafibrate in people with type 2 diabetes and elevated triglyceride levels: 52-week data from the PROVIDE study.
Diabetes Obes Metab
; 21(7): 1737-1744, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-30830727
16.
Achieving LDL cholesterol target levels <1.81 mmol/L may provide extra cardiovascular protection in patients at high risk: Exploratory analysis of the Standard Versus Intensive Statin Therapy for Patients with Hypercholesterolaemia and Diabetic Retinopathy study.
Diabetes Obes Metab
; 21(4): 791-800, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30393955
17.
Inflammasome Activation Aggravates Cutaneous Xanthomatosis and Atherosclerosis in ACAT1 (Acyl-CoA Cholesterol Acyltransferase 1) Deficiency in Bone Marrow.
Arterioscler Thromb Vasc Biol
; 38(11): 2576-2589, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30354239
18.
Myeloid HMG-CoA (3-Hydroxy-3-Methylglutaryl-Coenzyme A) Reductase Determines Atherosclerosis by Modulating Migration of Macrophages.
Arterioscler Thromb Vasc Biol
; 38(11): 2590-2600, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30354246
19.
Efficacy and Safety of Pemafibrate, a Novel Selective Peroxisome Proliferator-Activated Receptor α Modulator (SPPARMα): Pooled Analysis of Phase 2 and 3 Studies in Dyslipidemic Patients with or without Statin Combination.
Int J Mol Sci
; 20(22)2019 Nov 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31698825
20.
Long-Term Efficacy and Safety of Pemafibrate, a Novel Selective Peroxisome Proliferator-Activated Receptor-α Modulator (SPPARMα), in Dyslipidemic Patients with Renal Impairment.
Int J Mol Sci
; 20(3)2019 Feb 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30736366